Close

Glioblastoma

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Overview

Glioblastoma, also known as glioblastoma multiforme (GBM) and grade IV astrocytoma, which is the most common glioma that starts in the glial cells within the brain. Glioblastoma has a tendency of spreading quickly throughout the brain, but It can also originate from a lower grade, less cancerous brain tumor. Although glioblastoma commonly locates in the cerebral hemisphere near the frontal and temporal lobes. it can also begin from other areas in the brain. About five out of every one hundred thousand people are diagnosed with glioblastoma in America every year. And it is usually diagnosed in people with the age from about 50 to 70 and affect slightly more male than female. The exact factors that cause this disease are not very clear.

Signs, symptoms and treatments

Glioblastoma can cause an series of symptoms as most primary brain tumors, which may include: headaches, nausea and vomiting, progressive cognitive dysfunction (e.g. memory loss, numbness), blurry vision and behavioral changes. Surgery is helpful to confirm the diagnosis and relieve headache, while radiation therapy and chemotherapy also play important roles in decreasing tumor size, prolonging survival time and increasing quality of life.

Loading...
Products
Global Services
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.